First FDA-Cleared Blood Test for Alzheimer’s Disease Launches
The test offers a less invasive alternative to cerebrospinal fluid testing and PET scans for detecting amyloid plaques.
Read MorePosted by Edisource Vendor | Aug 18, 2025 | Dementias & Alzheimer’s |
The test offers a less invasive alternative to cerebrospinal fluid testing and PET scans for detecting amyloid plaques.
Read MorePosted by Edisource Vendor | Aug 15, 2025 | Allergy & Autoimmune |
New research demonstrates BAT outperforms standard allergy tests in children under 2, potentially reducing need for oral food challenges by nearly half.
Read MorePosted by Edisource Vendor | Aug 15, 2025 | Cancer |
Dana-Farber Cancer Institute, Boston Children’s Hospital, and Broad Clinical Labs form BrightSeq collaborative to develop novel clinical diagnostic assays for rare pediatric cancers.
Read MorePosted by Alyx Arnett | Aug 14, 2025 | Cervical (HPV) |
This marks the first time a US Food and Drug Adminstration-authorized self-collection device is available for at-home cervical cancer screening in the US.
Read MorePosted by Alyx Arnett | Aug 14, 2025 | Research |
Scientists have documented a notable case of antibiotic resistance evolving within a critically ill patient during treatment for an E. coli bloodstream infection, providing genomic evidence of how drug resistance can emerge in real time.
Read More